Rosiglitazone is more effective than metformin in improving fasting indexes of glucose metabolism in severely obese, non-diabetic patients. (Q51474253)
Jump to navigation
Jump to search
scientific article published on 29 March 2007
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Rosiglitazone is more effective than metformin in improving fasting indexes of glucose metabolism in severely obese, non-diabetic patients. |
scientific article published on 29 March 2007 |
Statements
1 reference
Rosiglitazone is more effective than metformin in improving fasting indexes of glucose metabolism in severely obese, non-diabetic patients. (English)
1 reference
Brunani A
1 reference
Caumo A
1 reference
Graci S
1 reference
Castagna G
1 reference
Viberti G
1 reference
Liuzzi A
1 reference
29 March 2007
1 reference
10
1 reference
6
1 reference
460-467
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference